The share market was not favorable for the renowned British drug company AstraZeneca (AZN.L) on Monday. The shares of AstraZeneca fell by 2.1% in the early trades of Monday after reports came in that the company had approached Gilead Sciences (GILD.O), its U.S. rival, for a possible merger. The […]